Meteoric Biopharmaceuticals Private Limited, a active private limited company, was established on 13 April 2006 in Ahmedabad, Gujarat, India. Engaging in industrial enzymes & biochemicals within the trade sector, it holds CIN: U51100GJ2006PTC048129. Registered under ROC Roc Ahmedabad. it is unlisted. It has an authorized capital of ₹1.50 Cr and a paid-up capital of ₹1.50 Cr.
Formerly known as Meteoric Exim Private Limited. It upholds a compliant status. Employing 77 professional, Its leadership includes Poonam Kailash Gupta (Director), Gaurav Kaushik (Director). Past directors included Poonam Kailash Gupta, Kunjal Harshvadanbhai Patel, Gaurav Kaushik. It holds ₹45.15 Cr open charges and ₹3.50 Cr settled loans. Its latest AGM occurred on 30 September 2024, with the balance sheet filed on 31 March 2024. It is based at 901-904, 9Th Floor, Earth Arise, S G Highway, Makarba, Ahmedabad - 380015, Ahmedabad, Gujarat, 380015.
U51100GJ2006PTC048129
048129
13 April 2006
₹1.50 Cr
₹1.50 Cr
Roc Ahmedabad
Unlisted
Active
Explore comprehensive insights into Meteoric Biopharmaceuticals Private Limited — covering financial performance, compliance records, Competitor, shareholding patterns, directors, key metrics, and litigation history. Unlock to see detailed insights and stay informed.
Access Report
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
| Poonam Kailash Gupta | Director | 02 Jan 2019 | Current |
| Gaurav Kaushik | Director | 30 Jun 2009 | Current |
| Name | Designation | Cessation | Status |
|---|---|---|---|
| Pramod Abcsdd | Director | 14 Oct 2013 | Past |
| Pramod Abcsdd | Director | 30 Jun 2023 | Past |
| Pramod Abcsdd | Managing Director | 24 Sep 2009 | Past |
| Pramod Abcsdd | Director | 23 Feb 2011 | Past |
Discover detailed profiles of directors and KMP - Unlock leadership insights today!
Meteoric Biopharmaceuticals Private Limited, for the financial year ended 2023, experienced significant growth in revenue, with a 20.42% increase. The company also saw a substantial improvement in profitability, with a 52.06% increase in profit. The company's net worth Soared by an impressive increase of 47.2%.
| Metrics |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
| ||||||
| Revenue from Operations |
| ||||||
| Total Assets |
| ||||||
| Profit or Loss |
| ||||||
| Net Worth |
| ||||||
| EBITDA |
|
In 2023, Meteoric Biopharmaceuticals had a promoter holding of 99.56% and a public holding of 0.44%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
Reveal ownership structures and financial performance - Get instant access now!
₹451,500,000.00
₹35,000,000.00
| Date | Lender | Amount | Status |
|---|---|---|---|
| 03 Apr 2024 | Axis Bank Limited | ₹45.15 Cr | Open |
| 20 Nov 2021 | Others | ₹1.50 Cr | Satisfied |
| 21 Oct 2021 | Sidbi | ₹2.00 Cr | Satisfied |
Explore comprehensive loan charge details -
Meteoric Biopharmaceuticals has a workforce of 77 employees as of Oct 06, 2024. Unlock access to detailed historical data on individuals associated with the company, including employment records, contributions to the Employees' Provident Fund Organization (EPFO), and other related insights.
Gain comprehensive insights into the Deals and Valuation data of Meteoric Biopharmaceuticals, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Meteoric Biopharmaceuticals's trajectory.
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
The activity A charge with Axis Bank Limited of Rs. 45.15 Cr registered on 03 Apr 2024 with Charge ID 100909896 was modified on 13 May 2025. was completed.
Progress on Meteoric Biopharmaceuticals Private Limited last Annual general meeting of members was held on 30 Sep 2024 as per latest MCA records. was documented.
The activity A charge with Axis Bank Limited amounted to Rs. 45.15 Cr with Charge ID 100909896 was registered on 03 Apr 2024. was completed.
The activity Meteoric Biopharmaceuticals Private Limited has filed its annual Financial statements for the year ended 31 Mar 2024 with Roc Ahmedabad. was completed.
The activity A charge registered on 20 Nov 2021 via Charge ID 100501202 with Others was fully satisfied on 15 Feb 2024. was completed.
Progress on A charge registered on 21 Oct 2021 via Charge ID 100491251 with Sidbi was fully satisfied on 21 Apr 2023. was documented.
The CIN of Meteoric Biopharmaceuticals Private Limited is U51100GJ2006PTC048129.
Meteoric Biopharmaceuticals Private Limited is headquartered at 901-904, 9Th Floor, Earth Arise, S G Highway, Makarba, Ahmedabad - 380015, Ahmedabad, Gujarat, 380015.
Meteoric Biopharmaceuticals Private Limited was incorporated on 13 April 2006.
The current directors of Meteoric Biopharmaceuticals Private Limited are
The primary industry of Meteoric Biopharmaceuticals Private Limited is Trade.
Meteoric Biopharmaceuticals Private Limited is unlisted.
The authorized capital of Meteoric Biopharmaceuticals Private Limited is ₹1.50 Cr, and the paid-up capital is ₹1.50 Cr.
The compliance status of Meteoric Biopharmaceuticals Private Limited is Compliant.
Search company & director profiles for free and gain access to critical business data.
Company Details
+91-XXXXXXXXXX